As of 4:00pm ET
| +0.64 / +18.71%|
The 1 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a -26.11% decrease from the last price of 4.06.
The current consensus among 2 polled investment analysts is to Hold stock in Pernix Therapeutics Holdings Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.